Yamamura H, Tatsuta M, Ito M, Iishi H, Noguchi S, Okuda S, Yoshida M
Department of Gastrointestinal Oncology, Center for Adult Diseases, Osaka, Japan.
Pancreas. 1989;4(4):401-5. doi: 10.1097/00006676-198908000-00002.
The accuracies of assays of serum CA 19-9 and elastase 1 in the diagnosis of pancreatic carcinoma were investigated by the cutoff method and discriminant analysis of data on 98 patients with pancreatitis, 65 patients with pancreatic carcinoma, 107 patients with benign diseases of other organs, and 108 patients with cancer of other organs. Comparison of the diagnostic accuracies of the cutoff method and multivariate analysis of CA 19-9 and elastase 1 showed that the latter was better for diagnosis in terms of its specificity. The performance of multivariate analysis was validated on independent data consisting of 52 patients with pancreatitis, 27 patients with pancreatic carcinoma, 79 patients with benign diseases of other organs, and 29 patients with cancer of other organs. Multivariate analysis of CA 19-9 and elastase 1 was very useful for differentiation of patients with and without pancreatic carcinoma: 24 (88.9%) of 27 patients with pancreatic carcinoma were correctly classified. Moreover, by this method, all patients with pancreatic carcinoma of less than 2 cm in longest diameter and 81.3% of those without jaundice were correctly classified.
采用截断值法和判别分析,对98例胰腺炎患者、65例胰腺癌患者、107例其他器官良性疾病患者和108例其他器官癌症患者的数据进行分析,以研究血清CA 19-9和弹性蛋白酶1检测在胰腺癌诊断中的准确性。对CA 19-9和弹性蛋白酶1的截断值法诊断准确性与多变量分析进行比较,结果显示,就特异性而言,后者在诊断方面表现更佳。多变量分析的性能在由52例胰腺炎患者、27例胰腺癌患者、79例其他器官良性疾病患者和29例其他器官癌症患者组成的独立数据上得到验证。CA 19-9和弹性蛋白酶1的多变量分析对于区分有无胰腺癌的患者非常有用:27例胰腺癌患者中有24例(88.9%)被正确分类。此外,通过这种方法,所有最长直径小于2 cm的胰腺癌患者以及81.3%无黄疸的患者均被正确分类。